Pressure-wire Guided PTCA: Drug Eluting Stent Versus Drug Eluting Balloon (WinDEB Study)

NCT01399463 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-07-21

No results posted yet for this study

Summary

The aim of the study is to show the safety and efficacy of the SeQuent® Please (Drug Eluting Balloon or DEB) vs. commonly used Drug Eluting Stents in the treatment of small vessel disease and side branches by pressure wire guided percutaneous coronary intervention.

Conditions

Interventions

DEVICE

Angioplasty performed via Paclitaxel Eluting Balloon catheter

DEVICE

Angioplasty via DES

Angioplasty performed via commonly used Drug Eluting Stents

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Study Design

Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01399463 on ClinicalTrials.gov